In OPA1-related dominant optic atrophy patients, the metabolic profile showed an impairment of the purine metabolism, including significant differences in xanthine, hypoxanthine, and inosine concentrations. The gene discussed is OPA1; the disease is autosomal dominant optic atrophy.